All Posts:Center for Cell Reprogramming
-
Conditional Reprogramming: A Novel Way to Study the Novel Coronavirus
(July 8, 2020) — Even during the early days of the pandemic, it was apparent that some patients with COVID-19 develop multisystem problems in addition to respiratory infections. Specifically, the virus can cause life-threatening gastrointestinal, cardiac, neurological and renal complications. These severe cases appear to occur because the virus rapidly replicates in various organs, causing […]
Category: GUMC Stories
-
Scientists Describe Lab Technique With Potential To Change Medicine and Research
Researchers who developed and tested a revolutionary laboratory technique that allows for the endless growth of normal and diseased cells in a laboratory are publicly sharing how the technique works.
Category: News Release
-
Mechanistic Insight into Immortal Cells Could Speed Clinical Use
WASHINGTON — The mechanistic understanding of the relatively new technique for growing cells in culture indefinitely – known as conditional reprogramming – has been deciphered and reported in the February 25th issue of PLOS ONE. Researchers at Georgetown Lombardi Comprehensive Cancer Center say identifying the mechanisms of immortalization lays the groundwork for future clinical use of these cells.
Category: News Release
-
Center for Cellular Reprogramming Created To Drive Laboratory Breakthrough
Georgetown University Medical Center announces the launch of the Center for Cellular Reprogramming, a global center of excellence whose mission is to promote intra- and extramural collaborations, education and development, centered around the use of stem-like cells.
Category: News Release
-
Schlegel Honored for Research and Teaching with New University Award
Richard Schlegel, MD, PhD, chair of the department of pathology and professor of oncology at Georgetown Lombardi Comprehensive Cancer Center, received the President’s Award for Distinguished Scholar-Teaching.
Category: GUMC Stories
-
HPV News Provides a Shot in the Arm
(July 10, 2013) — June 19 was a very good day for Richard Schlegel, MD, PhD, a pathologist at Georgetown University Medical Center who is known worldwide as a co-inventor of the technology behind the
Category: GUMC Stories
-
New Center Serves as Research Hub
(March 20, 2013) — It quickly became known as the “Georgetown method.” A revolutionary way of growing both tumor and normal cells in order to one day truly personalize therapy has drawn scientists fr
Category: GUMC Stories